Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1933 1
1945 1
1946 1
1948 3
1952 1
1961 2
1963 1
1964 2
1965 1
1968 3
1969 9
1970 3
1971 6
1972 10
1973 3
1974 4
1975 6
1976 10
1977 14
1978 5
1979 10
1980 8
1981 8
1982 8
1983 12
1984 9
1985 12
1986 18
1987 22
1988 17
1989 15
1990 21
1991 36
1992 34
1993 77
1994 58
1995 65
1996 100
1997 142
1998 253
1999 275
2000 347
2001 426
2002 440
2003 530
2004 580
2005 765
2006 671
2007 647
2008 754
2009 785
2010 728
2011 717
2012 666
2013 715
2014 698
2015 655
2016 686
2017 674
2018 651
2019 692
2020 851
2021 905
2022 827
2023 752
2024 322

Text availability

Article attribute

Article type

Publication date

Search Results

16,189 results

Results by year

Filters applied: . Clear all
Page 1
Mycophenolate mofetil.
Sievers TM, Rossi SJ, Ghobrial RM, Arriola E, Nishimura P, Kawano M, Holt CD. Sievers TM, et al. Pharmacotherapy. 1997 Nov-Dec;17(6):1178-97. Pharmacotherapy. 1997. PMID: 9399601 Review.
Mycophenolate mofetil is the morpholinoethylester prodrug of mycophenolic acid, an agent that inhibits the proliferation of B and T lymphocytes through noncompetitive, reversible inhibition of inosine monophosphate dehydrogenase, a key enzyme in the de …
Mycophenolate mofetil is the morpholinoethylester prodrug of mycophenolic acid, an agent that inhibits the proli …
Mycophenolate mofetil.
Zwerner J, Fiorentino D. Zwerner J, et al. Dermatol Ther. 2007 Jul-Aug;20(4):229-38. doi: 10.1111/j.1529-8019.2007.00136.x. Dermatol Ther. 2007. PMID: 17970888 Review.
Mycophenolate mofetil (MMF) is a relatively new systemic immunosuppressive agent whose use is rapidly increasing within the field of dermatologic. ...
Mycophenolate mofetil (MMF) is a relatively new systemic immunosuppressive agent whose use is rapidly increasing within the fi …
Mycophenolate Mofetil Treatment of C3 Glomerulopathy.
Peleg Y, Appel GB. Peleg Y, et al. Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1234-1236. doi: 10.2215/CJN.11740720. Epub 2020 Aug 19. Clin J Am Soc Nephrol. 2020. PMID: 32841154 Free PMC article. No abstract available.
Mycophenolate mofetil.
Lipsky JJ. Lipsky JJ. Lancet. 1996 Nov 16;348(9038):1357-9. doi: 10.1016/S0140-6736(96)10310-X. Lancet. 1996. PMID: 8918281 Review. No abstract available.
Mycophenolate mofetil.
Sollinger HW. Sollinger HW. Kidney Int Suppl. 1995 Dec;52:S14-7. Kidney Int Suppl. 1995. PMID: 8587275 Review.
Mycophenolate mofetil (MMF), the morpholinoethyl ester of mycophenolic acid (MPA), is a new selective immunosuppressant used for the prevention and treatment of acute renal rejection after transplantation. ...
Mycophenolate mofetil (MMF), the morpholinoethyl ester of mycophenolic acid (MPA), is a new selective immunosupp …
The use of mycophenolate mofetil area under the curve.
Chakrabarti K, Frame D, Al Abbas M, McCune WJ. Chakrabarti K, et al. Curr Opin Rheumatol. 2021 May 1;33(3):221-232. doi: 10.1097/BOR.0000000000000799. Curr Opin Rheumatol. 2021. PMID: 33741807 Review.
PURPOSE OF REVIEW: Although mycophenolate mofetil (MMF) has been used successfully to treat a myriad of autoimmune diseases, its complex pharmacokinetics make it difficult to determine the true drug exposure for an individual patient. This review summarizes the body …
PURPOSE OF REVIEW: Although mycophenolate mofetil (MMF) has been used successfully to treat a myriad of autoimmune diseases, i …
Mycophenolate mofetil in dermatology.
Orvis AK, Wesson SK, Breza TS Jr, Church AA, Mitchell CL, Watkins SW. Orvis AK, et al. J Am Acad Dermatol. 2009 Feb;60(2):183-99; quiz 200-2. doi: 10.1016/j.jaad.2008.08.049. J Am Acad Dermatol. 2009. PMID: 19150270 Review.
Mycophenolate mofetil (MMF) is the prodrug of mycophenolic acid (MPA), a medication used to treat psoriasis in the 1970s until side effects and the concern of carcinogenesis led to its discontinuation. ...LEARNING OBJECTIVE: After completing this learn …
Mycophenolate mofetil (MMF) is the prodrug of mycophenolic acid (MPA), a medication used to treat psoriasis in t …
Mycophenolate mofetil: An update.
Villarroel MC, Hidalgo M, Jimeno A. Villarroel MC, et al. Drugs Today (Barc). 2009 Jul;45(7):521-32. doi: 10.1358/dot.2009.45.7.1384878. Drugs Today (Barc). 2009. PMID: 19834629 Review.
Mycophenolic acid (MPA) is a potent, selective, noncompetitive and reversible inhibitor of inosine-5'-monophosphate deshydrogenase (IMPDH). ...After oral administration, MMF is completely metabolized to MPA. A major inactive metabolite, mycophenolic acid …
Mycophenolic acid (MPA) is a potent, selective, noncompetitive and reversible inhibitor of inosine-5'-monophosphate deshydroge …
Mycophenolate mofetil in liver transplantation: a review.
Kaltenborn A, Schrem H. Kaltenborn A, et al. Ann Transplant. 2013 Dec 18;18:685-96. doi: 10.12659/AOT.889299. Ann Transplant. 2013. PMID: 24346057 Free article. Review.
The most common adverse effects of mycophenolate mofetil are gastrointestinal complaints such as diarrhea, which often lead to dose-reduction or withdrawal of mycophenolate mofetil. A newer, enteric-coated formulation is available, which is meant to re …
The most common adverse effects of mycophenolate mofetil are gastrointestinal complaints such as diarrhea, which often lead to …
Mycophenolate mofetil in primary glomerulopathies.
Sepe V, Libetta C, Giuliano MG, Adamo G, Dal Canton A. Sepe V, et al. Kidney Int. 2008 Jan;73(2):154-62. doi: 10.1038/sj.ki.5002653. Epub 2007 Nov 7. Kidney Int. 2008. PMID: 17989649 Free article. Review.
Mycophenolate mofetil is not nephrotoxic like calcineurin inhibitors and is widely used in solid-organ transplantation. Recently, mycophenolate mofetil has been introduced in the treatment of autoimmune diseases and primary glomerulopathies. ...
Mycophenolate mofetil is not nephrotoxic like calcineurin inhibitors and is widely used in solid-organ transplantation. Recent …
16,189 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "mycophenolate mofetil"